Dillard's, Inc.
DDS · NYSE
2/1/2025 | 2/3/2024 | 1/28/2023 | 1/29/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.72 | -0.73 | 0.35 | -0.00 |
| FCF Yield | 8.08% | 11.61% | 12.43% | 22.74% |
| EV / EBITDA | 7.78 | 5.47 | 4.89 | 3.79 |
| Quality | ||||
| ROIC | 22.23% | 28.32% | 36.51% | 37.93% |
| Gross Margin | 40.52% | 41.36% | 43.06% | 43.43% |
| Cash Conversion Ratio | 1.20 | 1.20 | 1.06 | 1.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.97% | 1.24% | 16.43% | 1.46% |
| Free Cash Flow Growth | -18.79% | -9.37% | -29.55% | 510.75% |
| Safety | ||||
| Net Debt / EBITDA | -0.17 | -0.21 | -0.07 | -0.08 |
| Interest Coverage | 18.56 | 22.75 | 25.99 | 24.88 |
| Efficiency | ||||
| Inventory Turnover | 3.34 | 3.68 | 3.56 | 3.47 |
| Cash Conversion Cycle | 56.25 | 51.35 | 51.59 | 46.14 |